Novo Nordisk says Hims &
Photo: Richard Drew AP/TT

Novo Nordisk says Hims & Hers plan to sell a copy of Wegovy pill is illegal

Novo Nordisk shares continue to fall after competitor Hims & Hers Health announced that it is launching a cheap copy of a slimming preparation. "An illegal product that poses a significant risk to patient safety," the Danish manufacturer believes.

Advertisement

Novo Nordisk shares are down another 8 percent after an article from Reuters stating that U.S.-based Hims & Hers Health will begin selling cheaper copies of Novo Nordisk's new Wegovy pill at $49 per month.

In a press release, Novo Nordisk opposed the plans and said the company will "take legal and regulatory action to protect patients, our intellectual property rights and the integrity of the US drug approval framework."

Hims & Hers shares were up 1.1 percent on Wall Street.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All